NYSE:EVH - Evolent Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$16.80 +0.41 (+2.50 %)
(As of 02/18/2019 04:00 PM ET)
Previous Close$16.39
Today's Range$16.3298 - $17.03
52-Week Range$13.61 - $29.05
Volume2.14 million shs
Average Volume1.03 million shs
Market Capitalization$1.38 billion
P/E Ratio-24.00
Dividend YieldN/A
Beta1.38
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Management services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
Phone571-389-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$434.95 million
Book Value$13.52 per share

Profitability

Net Income$-60,660,000.00

Miscellaneous

Employees2,600
Market Cap$1.38 billion
OptionableOptionable

Evolent Health (NYSE:EVH) Frequently Asked Questions

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

How were Evolent Health's earnings last quarter?

Evolent Health Inc (NYSE:EVH) issued its quarterly earnings results on Tuesday, August, 7th. The technology company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.01. The technology company had revenue of $144.51 million for the quarter, compared to the consensus estimate of $141.90 million. Evolent Health had a negative net margin of 9.05% and a negative return on equity of 2.18%. View Evolent Health's Earnings History.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Evolent Health.

How can I listen to Evolent Health's earnings call?

Evolent Health will be holding an earnings conference call on Tuesday, February 26th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8559409467.

What price target have analysts set for EVH?

10 brokers have issued 12 month price targets for Evolent Health's stock. Their predictions range from $25.00 to $37.00. On average, they expect Evolent Health's share price to reach $32.4444 in the next twelve months. This suggests a possible upside of 93.1% from the stock's current price. View Analyst Price Targets for Evolent Health.

What is the consensus analysts' recommendation for Evolent Health?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evolent Health.

What are Wall Street analysts saying about Evolent Health stock?

Here are some recent quotes from research analysts about Evolent Health stock:
  • 1. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (1/29/2019)
  • 2. Cantor Fitzgerald analysts commented, "We reaffirm our Overweight rating and $37 PT on EVH. EVH’s population health-management tools enable healthcare organizations to transition to value-based reimbursement. Its primary customers include captive health insurance plans of large, integrated delivery networks. Given the ongoing shift to value-based reimbursement, we believe EVH is well-positioned to grow rapidly given the large addressable market. Despite some concerns about the future of the Affordable Care Act (ACA), we believe market forces will continue to drive the shift to value-based reimbursement in many large population markets." (12/31/2018)

Has Evolent Health been receiving favorable news coverage?

News articles about EVH stock have been trending positive on Monday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Evolent Health earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave headlines about the technology company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the near term.

Who are some of Evolent Health's key competitors?

Who are Evolent Health's key executives?

Evolent Health's management team includes the folowing people:
  • Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 52)
  • Mr. Seth Blackley, Co-Founder, Pres & Director (Age 40)
  • Mr. Thomas Peterson III, Co-Founder & COO (Age 49)
  • Mr. Nicholas McGrane, Chief Financial Officer (Age 51)
  • Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 43)

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Bank of New York Mellon Corp (6.55%), BlackRock Inc. (5.68%), Riverbridge Partners LLC (4.62%), Dimensional Fund Advisors LP (3.94%), Eagle Asset Management Inc. (2.86%) and Standard Life Aberdeen plc (2.56%). Company insiders that own Evolent Health stock include Board Co Advisory, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc, Unitedhealth Group Inc and Upmc. View Institutional Ownership Trends for Evolent Health.

Which institutional investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Bank of New York Mellon Corp, Monarch Partners Asset Management LLC, Columbus Circle Investors, Granite Investment Partners LLC, Oak Ridge Investments LLC, CWM LLC and Tekla Capital Management LLC. Company insiders that have sold Evolent Health company stock in the last year include Cheryl Scott, Frank J Williams, Jonathan Weinberg, Lydia Stone, Seth Blackley, Thomas Peterson III and Unitedhealth Group Inc. View Insider Buying and Selling for Evolent Health.

Which institutional investors are buying Evolent Health stock?

EVH stock was acquired by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., Riverbridge Partners LLC, Standard Life Aberdeen plc, Nicholas Company Inc., Westfield Capital Management Co. LP, Elk Creek Partners LLC, Tygh Capital Management Inc. and Gabelli Funds LLC. View Insider Buying and Selling for Evolent Health.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $16.80.

How big of a company is Evolent Health?

Evolent Health has a market capitalization of $1.38 billion and generates $434.95 million in revenue each year. The technology company earns $-60,660,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis. Evolent Health employs 2,600 workers across the globe.

What is Evolent Health's official website?

The official website for Evolent Health is http://www.evolenthealth.com.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.


MarketBeat Community Rating for Evolent Health (NYSE EVH)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  380 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  578
MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe EVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Featured Article: Bull Market

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel